Welcome to the NICE Decision Support Unit

The latest news from the DSU


Degarelix for prostate cancer
DSU report: Spinal cord compression associated with hormonal therapy in men with hormone-dependent metastatic prostate cancer: A systematic review and economic assessment (made available online June 2015)

Observational data TSD
TSD17: The use of observational data to inform estimates of treatment effectiveness in technology appraisal: Methods for comparative individual patient data (May 2015) 

Econometric Mapping of Utilities - Stata command
Publication: ALDVMM: A command for fitting Adjusted Limited Dependent Variable Mixture Models to EQ-5D (made available online May 2015)

Not cost-effective at zero price
Assessing technologies that are not cost-effective at a zero price (made available online November 2014)

End of Life
Publication: Valuing health at the end of life: a stated preference discreet choice experiment (Jan 2015)

Mapping of EQ-5D
Publication: A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes (Oct 2014)

DSU report on the effects of cancer treatment on quality of life (September 2014)

Treatment switching TSD
TSD 16: Adjusting survival time estimates in the presence of treatment switching (July 2014)

Bevacizumab for eye conditions 
Publication: The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review (July 2014)

Patient-level simulation TSD
TSD 15: Cost-effectiveness modelling using patient-level simluation (April 2014)

Value based pricing / assessment
4 DSU reports on the implementation of value based pricing (now value based assessment)


The DSU is currently involved in work in the following areas:

To receive notification when these reports or documents are uploaded on to this website, please join our mailing list by entering your details on the right of this page or follow us on Twitter @NICE_DSU